Free, scientifically validated WHO self-test in 3 minutes. If your screening is positive: full diagnostic consult with an experienced physician, written report.
The ASRS is a screening instrument by the WHO, not a substitute for diagnosis. Only the physician can establish a DSM-5 / ICD-11 diagnosis.
18 questions, ~3 min. Anonymous or with account. GDPR-compliant.
45–60 min video session, full DSM-5 / ICD-11 anamnesis, written report.
No. 1 consultation €10.72 + no. 801 psychiatric examination €33.52 + no. 75 written report €17.43, each at factor 2.3. €10.72 is reserved at booking; the remainder is billed after the consultation.
Only for diagnosed patients. Non-controlled medication only.
GOÄ Nr. 1 × Faktor 2,30
We do NOT prescribe controlled-substance stimulants (methylphenidate, lisdexamfetamine, dexamphetamine) via OpenClinic24 telemedicine. These require an in-person visit with a psychiatrist and are legally not permitted via telemedicine in Germany. We may prescribe: atomoxetine, guanfacine, and off-label bupropion.
No. The WHO ASRS is a screening questionnaire. A formal diagnosis per DSM-5 / ICD-11 is established only by the physician during a consultation.
No — methylphenidate, lisdexamfetamine and dexamphetamine are controlled substances and cannot be prescribed via telemedicine in Germany. We may prescribe atomoxetine, guanfacine, and off-label bupropion.
Adi Zoabi (general medicine) evaluates all findings and establishes a formal DSM-5 / ICD-11 diagnosis during a 45–60 minute consultation.
45–60 minutes. Includes structured anamnesis, differential diagnostics, and a written report.
The self-test is free. The diagnostic consultation costs 61.67 €: GOÄ no. 1 (consultation, 10.72 €) + no. 801 (in-depth psychiatric examination, 33.52 €) + no. 75 (detailed written report, 17.43 €), each at factor 2.3. 10.72 € is reserved on your card at booking; the remainder is billed after the consultation. Every item appears on the invoice with its code, factor and amount. Renewal consultation 10.72 € (GOÄ no. 1 × factor 2.3).